BG 10-Q report for 2025-09-30
This play documents the existence of Bunge Global SA’s Form 10‑Q for the quarter ended September 30, 2025. The excerpt available is the SEC cover page/filing header and provides issuer identity, exchange listing (BG — NYSE), addresses, and filing checkboxes. The filing cover page alone contains no financial results, management discussion, guidance, liquidity metrics, or material-event disclosures.
Linked assets
BG — Bunge Global SA: cover-page filing metadata for the 10‑Q dated September 30, 2025. No operational or financial detail in the excerpt.
Bunge Global SA — Form 10‑Q cover page for quarter ended September 30, 2025; confirms filing and listing (BG, NYSE) but contains no substantive financial or operational disclosures in the excerpt provided.
BG 10-Q report for 2025-09-30 bg-20250930 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-56607 BUNGE GLOBAL SA (Exact name of registrant as specified in its charter) Switzerland 98-1743397 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Route de Florissant 13 1206 Geneva , Switzerland N.A. (Address of registered office and principal executive office) (Zip Code) 1391 Timberlake Manor Parkway Chesterfield, Missouri 63017 (Address of corporate headquarters) (Zip Code) ( 314 ) 292-2000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Registered Shares, $0.01 par value per share BG New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a sma
Source proof
Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review
The source excerpt is the SEC Form 10‑Q cover page for Bunge Global SA (Commission File Number 000-56607) for the quarterly period ended September 30, 2025. It confirms the registrant name, jurisdiction (Switzerland), registered shares trading on the New York Stock Exchange under ticker BG, corporate addresses, and routine SEC filing confirmations. There are no financial statements, MD&A, risk-factor updates, or other substantive disclosures in the provided text.
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
The provided text is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.
This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.
This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.
This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.
The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.
Supporting authors
Authored/curated by 1 contributor. No additional analyst commentary or financial modeling is included — the play is based solely on the filing-header excerpt.
Unlock full thesis monitoring
Recommended strategy: sell (status: active). Note: recommendation is based on the limited informational content of the cover-page excerpt; users should review the full Form 10‑Q for financial results and material disclosures before taking action.